Correlation Between Neoleukin Therapeutics and Ocular Therapeutix
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Ocular Therapeutix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Ocular Therapeutix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Ocular Therapeutix, you can compare the effects of market volatilities on Neoleukin Therapeutics and Ocular Therapeutix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Ocular Therapeutix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Ocular Therapeutix.
Diversification Opportunities for Neoleukin Therapeutics and Ocular Therapeutix
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neoleukin and Ocular is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Ocular Therapeutix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocular Therapeutix and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Ocular Therapeutix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocular Therapeutix has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Ocular Therapeutix go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Ocular Therapeutix
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to under-perform the Ocular Therapeutix. But the stock apears to be less risky and, when comparing its historical volatility, Neoleukin Therapeutics is 1.12 times less risky than Ocular Therapeutix. The stock trades about -0.07 of its potential returns per unit of risk. The Ocular Therapeutix is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 761.00 in Ocular Therapeutix on August 31, 2024 and sell it today you would earn a total of 228.00 from holding Ocular Therapeutix or generate 29.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 8.56% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Ocular Therapeutix
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Ocular Therapeutix |
Neoleukin Therapeutics and Ocular Therapeutix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Ocular Therapeutix
The main advantage of trading using opposite Neoleukin Therapeutics and Ocular Therapeutix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Ocular Therapeutix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocular Therapeutix will offset losses from the drop in Ocular Therapeutix's long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Ocular Therapeutix vs. CytomX Therapeutics | Ocular Therapeutix vs. Assembly Biosciences | Ocular Therapeutix vs. Spero Therapeutics | Ocular Therapeutix vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |